1Yudkin, JS, Stehouwer, CD, Emeis, JJ, Coppack, SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arteriosclerosis Thrombosis and Vascular Biology 1999; 19 (4): 972–978.
2Bullo, M, Garcia-Lorda, P, Megias, I, Salas-Salvado, J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obesity Research 2003; 11 (4): 525–531.
3Horowitz, JF, Coppack, SW, Paramore, D, Cryer, PE, Zhao, G, Klein, S. Effect of short-term fasting on lipid kinetics in lean and obese women. American Journal of Physiology 1999; 276 (2 Pt 1): E278–E284.
4Samad, F, Yamamoto, K, Loskutoff, DJ. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide. Journal of Clinical Investigation 1996; 97 (1): 37–46.
5Samad, F, Pandey, M, Loskutoff, DJ. Tissue factor gene expression in the adipose tissues of obese mice. Proceedings of the National Academic of Science USA 1998; 95 (13): 7591–7596.
6De Pergola, G, Pannacciulli, N. Coagulation and fibrinolysis abnormalities in obesity. Journal of Endocrinology Investigation 2002; 25 (10): 899–904.
7Perreault, M, Marette, A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nature Medicine 2001; 7 (10): 1138–1143.
8Fried, SK, Bunkin, DA, Greenberg, AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. Journal of Clinical Endocrinology and Metabolism 1998; 83 (3): 847–850.
9Bullo, M, Garcia-Lorda, P, Peinado-Onsurbe, J, Hernandez, M, Del Castillo, D, Argiles, JM, et al. . TNFalpha expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis. International Journal of Obesity and Related Metabolic Disorders 2002; 26 (5): 652–658.
10Weisberg, SP, McCann, D, Desai, M, Rosenbaum, M, Leibel, RL, JrFerrante, AW. Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003; 112 (12): 1796–1808.
11Cinti, S, Mitchell, G, Barbatelli, G, Murano, I, Ceresi, E, Faloia, E, et al. . Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. Journal of Lipid Research 2005; 46 (11): 2347–2355.
12Cancello, R, Henegar, C, Viguerie, N, Taleb, S, Poitou, C, Rouault, C, et al. . Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005; 54 (8): 2277–2286.
13Stallone, DD. The influence of obesity and its treatment on the immune system. Nutrition Reviews 1994; 52 (2 Pt 1): 37–50.
14Cousin, B, Munoz, O, Andre, M, Fontanilles, AM, Dani, C, Cousin, JL, et al. . A role for preadipocytes as macrophage-like cells. FASEB Journal 1999; 13 (2): 305–312.
15Charriere, G, Cousin, B, Arnaud, E, Andre, M, Bacou, F, Penicaud, L, et al. . Preadipocyte conversion to macrophage. Evidence of plasticity. Journal of Biological Chemistry 2003; 278 (11): 9850–9855.
16Zhang, B, Berger, J, Hu, E, Szalkowski, D, White-Carrington, S, Spiegelman, BM, et al. . Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Molecular Endocrinology 1996; 10 (11): 1457–1466.
17Xu, H, Barnes, GT, Yang, Q, Tan, G, Yang, D, Chou, CJ, et al. . Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 2003; 112 (12): 1821–1830.
18Curat, CA, Miranville, A, Sengenes, C, Diehl, M, Tonus, C, Busse, R, et al. . From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004; 53 (5): 1285–1292.
19Lacasa, D, Taleb, S, Keophiphath, M, Miranville, A, Clement, K. Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. Endocrinology 2006; 148 (2): 868–877. November 2 [Epub ahead of print].
20Reaven, GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37 (12): 1595–1607.
21Ridker, PM, Rifai, N, Pfeffer, M, Sacks, F, Lepage, S, Braunwald, E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101 (18): 2149–2153.
22Souza, SC, Palmer, HJ, Kang, YH, Yamamoto, MT, Muliro, KV, Paulson, KE, et al. . TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes. Journal of Cellular Biochemistry 2003; 89 (6): 1077–1086.
23Bullo-Bonet, M, Garcia-Lorda, P, Lopez-Soriano, FJ, Argiles, JM, Salas-Salvado, J. Tumour necrosis factor, a key role in obesity? FEBS Letter 1999; 451 (3): 215–219.
24Kern, PA, Ranganathan, S, Li, C, Wood, L, Ranganathan, G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. American Journal of Physiology, Endocrinology and Metabolism 2001; 280 (5): E745–E751.
25van Hall, G, Steensberg, A, Sacchetti, M, Fischer, C, Keller, C, Schjerling, P, et al. . Interleukin-6 stimulates lipolysis and fat oxidation in humans. Journal of Clinical Endocrinology and Metabolism 2003; 88 (7): 3005–3010.
26Pradhan, AD, Manson, JE, Rifai, N, Buring, JE, Ridker, PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association 2001; 286 (3): 327–334.
27Ridker, PM, Rifai, N, Pfeffer, M, Sacks, F, Lepage, S, Braunwald, E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101 (18): 2149–2153.
28Gabay, C, Kushner, I. Acute-phase proteins and other systemic responses to inflammation. New England Journal of Medicine 1999; 340 (6): 448–454.
29Torres, JL, Ridker, PM. Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events. Current Opinion in Cardiology 2003; 18 (6): 471–478.
30Dixon, JB, O’Brien, PE. Obesity and the white blood cell count: changes with sustained weight loss. Obesity Surgery 2006; 16 (3):
31Arita, Y, Kihara, S, Ouchi, N, Takahashi, M, Maeda, K, Miyagawa, J, et al. . Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysics Research Communication 1999; 257 (1): 79–83.
32Bulló, M, Salas-Salvado, J, Garcia-Lorda, P. Adiponectin expression and adipose tissue lipolytic activity in lean and obese women. Obesity Surgery 2005; 15 (3): 382–386.
33Hotta, K, Funahashi, T, Arita, Y, Takahashi, M, Matsuda, M, Okamoto, Y, et al. . Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis and Vascular Biology 2000; 20 (6): 1595–1599.
34Ouchi, N, Kihara, S, Funahashi, T, Matsuzawa, Y, Walsh, K. Obesity, adiponectin and vascular inflammatory disease. Current Opinión in Lipidology 2003; 14 (6): 561–566.
35Tomas, E, Tsao, TS, Saha, AK, Murrey, HE, Zhang, Cc C, Itani, SI, et al. . Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proceedings of the National Academic of Science USA 2002; 99 (25): 16309–16313.
36Larsson, B, Svardsudd, K, Welin, L, Wilhelmsen, L, Bjorntorp, P, Tibblin, G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. British Medical Journal (Clinical Research Ed) 1984; 288 (6428): 1401–1404.
37Maeda, N, Takahashi, M, Funahashi, T, Kihara, S, Nishizawa, H, Kishida, K, et al. . PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001; 50 (9): 2094–2099.
38Matsuzawa, Y. The metabolic syndrome and adipocytokines. FEBS Letter 2006; 580 (12): 2917–2921.
39Fukuhara, A, Matsuda, M, Nishizawa, M, Segawa, K, Tanaka, M, Kishimoto, K, et al. . Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307 (5708): 426–430.
40Hammarstedt, A, Pihlajamaki, J, Rotter Sopasakis, V, Gogg, S, Jansson, PA, Laakso, M, et al. . Visfatin is an adipokine, but it is not regulated by thiazolidinediones. Journal of Clinical Endocrinology and Metabolism 2006; 91 (3): 1181–1184.
41Chen, MP, Chung, FM, Chang, DM, Tsai, JC, Huang, HF, Shin, SJ, et al. . Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 2006; 91 (1): 295–299.
42Fleischmann, E, Kurz, A, Niedermayr, M, Schebesta, K, Kimberger, O, Sessler, DI, et al. . Tissue oxygenation in obese and non-obese patients during laparoscopy. Obesity Surgery 2005; 15 (6): 813–819.
43Kabon, B, Nagele, A, Reddy, D, Eagon, C, Fleshman, JW, Sessler, DI, et al. . Obesity decreases perioperative tissue oxygenation. Anesthesiology 2004; 100 (2): 274–280.
44Lolmede, K, Durand de Saint Front, V, Galitzky, J, Lafontan, M, Bouloumie, A. Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. International Journal of Obesity and Related Metabolic Disorders 2003; 27 (10): 1187–1195.
45Segawa, K, Fukuhara, A, Hosogai, N, Morita, K, Okuno, Y, Tanaka, M, et al. . Visfatin in adipocytes is upregulated by hypoxia through HIF1alpha-dependent mechanism. Biochemistry and Biophysics Research Communication 2006; 349 (3): 875–882.
46Esposito, K, Pontillo, A, Di Palo, C, Giugliano, G, Masella, M, Marfella, R, et al. . Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. Journal of the American Medical Association 2003; 289 (14): 1799–1804.
47Troseid, M, Lappegard, KT, Claudi, T, Damas, JK, Morkrid, L, Brendberg, R, et al. . Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome. European Heart Journal 2004; 25 (4): 349–355.
48Haider, DG, Schindler, K, Schaller, G, Prager, G, Wolzt, M, Ludvik, B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. Journal of Clinical Endocrinology and Metabolism 2006; 91 (4): 1578–1581.
49Bastard, JP, Hainque, B, Dusserre, E, Bruckert, E, Robin, D, Vallier, P, et al. . Peroxisome proliferator activated receptor-gamma, leptin and tumor necrosis factor-alpha mRNA expression during very low calorie diet in subcutaneous adipose tissue in obese women. Diabetes and Metabolism Research Review 1999; 15 (2): 92–98.
50Viguerie, N, Vidal, H, Arner, P, Holst, C, Verdich, C, Avizou, S, et al. . Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets. Diabetologia 2005; 48 (1): 123–131.
51 Salas-Salvado J, Bullo M, Garcia-Lorda P, Figueredo R, Del Castillo D, Bonada A, et al. Subcutaneous adipose tissue cytokine production is not responsible for the restoration of systemic inflammation markers during weight loss. International Journal of Obesity (London) 2006; 30 (12): 1714–1720.
52Murdoch, C, Giannoudis, A, Lewis, CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 2004; 104 (8): 2224–2234.
53Trayhurn, P, Wood, IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition 2004; 92 (3): 347–355.
54Ridker, PM. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. American Heart Journal 2004; 148 (Suppl. 1): S19–S26.
55Danesh, J, Whincup, P, Walker, M, Lennon, L, Thomson, A, Appleby, P, et al. . Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. British Medical Journal 2000; 321 (7255): 199–204.
56Danesh, J, Wheeler, JG, Hirschfield, GM, Eda, S, Eiriksdottir, G, Rumley, A, et al. . C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine 2004; 350 (14): 1387–1397.
57Zhao, G, Etherton, TD, Martin, KR, Vanden Heuvel, JP, Gillies, PJ, West, SG, et al. . Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells. Biochemical Biophysics Research Communication 2005; 336 (3): 909–917.
58Miles, EA, Zoubouli, P, Calder, PC. Differential anti-inflammatory effects of phenolic compounds from extra virgin olive oil identified in human whole blood cultures. Nutrition 2005; 21 (3): 389–394.
59Manna, SK, Mukhopadhyay, A, Aggarwal, BB. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. Journal of Immunology 2000; 164 (12): 6509–6519.
60Giugliano, D, Marfella, R, Coppola, L, Verrazzo, G, Acampora, R, Giunta, R, et al. . Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 1997; 95 (7): 1783–1790.
61Giugliano, D, Ceriello, A, Esposito, K. The effects of diet on inflammation: emphasis on the metabolic syndrome. Journal of American College of Cardiology 2006; 48 (4): 677–685.
62Qi, L, Meigs, JB, Liu, S, Manson, JE, Mantzoros, C, Hu, FB. Dietary fibers and glycemic load, obesity, and plasma adiponectin levels in women with type 2 diabetes. Diabetes Care 2006; 29 (7): 1501–1505.
63Ma, Y, Griffith, JA, Chasan-Taber, L, Olendzki, BC, Jackson, E, 3rdStanek, EJ, et al. . Association between dietary fiber and serum C-reactive protein. American Journal of Clinical Nutrition 2006; 83 (4): 760–766.
64Ajani, UA, Ford, ES, Mokdad, AL. Dietary fiber and C-reactive protein findings from Nacional Health Nutrition Examination Survey data. Journal of Nutrition 2004; 134: 1181–1185.
65Liu, S, Buring, JE, Sesso, HD, Rimm, EB, Willett, WC, Manson, JE. A prospective study of dietary fiber intake and risk of cardiovascular disease among women. Journal of American Collage of Cardiology 2002; 39 (1): 49–56.
Pereira, MA, Kroenke, CH, Hilner, JE, Van Horn, L, Slattery, ML, et al. . Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. Journal of the American Medical Association 1999; 282 (16): 1539–1546.
67Pereira, MA, O’Reilly, E, Augustsson, K, Fraser, GE, Goldbourt, U, Heitmann, BL, et al. . Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Archives of Internal Medicine 2004; 164 (4): 370–376.
68Pischon, T, Hankinson, SE, Hotamisligil, GS, Rifai, N, Willett, WC, Rimm, EB. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003; 108 (2): 155–160.
69Lopez-Garcia, E, Schulze, MB, Manson, JE, Meigs, JB, Albert, CM, Rifai, N, et al. . Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. Journal of Nutrition 2004; 134 (7): 1806–1811.
70Zampelas, A, Panagiotakos, DB, Pitsavos, C, Das, UN, Chrysohoou, C, Skoumas, Y, et al. . Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA study. Journal of American College of Cardiology 2005; 46 (1): 120–124.
71Madsen, T, Skou, HA, Hansen, VE, Fog, L, Christensen, JH, Toft, E, et al. . C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. American Journal of Cardiology 2001; 88 (10): 1139–1142.
72Ciubotaru, I, Lee, YS, Wander, RC. Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. Journal of Nutrition Biochem 2003; 14 (9): 513–521.
73Rallidis, LS, Paschos, G, Liakos, GK, Velissaridou, AH, Anastasiadis, G, Zampelas, A. Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 2003; 167 (2): 237–242.
74Bemelmans, WJ, Lefrandt, JD, Feskens, EJ, van Haelst, PL, Broer, J, Meyboom-de Jong, B, et al. . Increased alpha-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis. European Journal of Clinical Nutrition 2004; 58 (7): 1083–1089.
75Zhao, G, Etherton, TD, Martin, KR, West, SG, Gillies, PJ, Kris-Etherton, PM. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. Journal of Nutrition 2004; 134 (11): 2991–2997.
76Lopez-Garcia, E, Schulze, MB, Meigs, JB, Manson, JE, Rifai, N, Stampfer, MJ, et al. . Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. Journal of Nutrition 2005; 135 (3): 562–566.
77Baer, DJ, Judd, JT, Clevidence, BA, Tracy, RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. American Journal of Clinical Nutrition 2004; 79 (6): 969–973.
78Lichtenstein, AH, Erkkila, AT, Lamarche, B, Schwab, US, Jalbert, SM, Ausman, LM. Influence of hydrogenated fat and butter on CVD risk factors: remnant-like particles, glucose and insulin, blood pressure and C-reactive protein. Atherosclerosis 2003; 171 (1): 97–107.
79Perez-Jimenez, F, Alvarez de Cienfuegos, G, Badimon, L, Barja, G, Battino, M, Blanco, A, et al. . International conference on the healthy effect of virgin olive oil. European Journal of Clinical Investigation 2005; 35 (7): 421–424.
80Fito, M, Cladellas, M, de la Torre, R, Marti, J, Alcantara, M, Pujadas-Bastardes, M, et al. . Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial. Atherosclerosis 2005; 181 (1): 149–158.
81Martinez-Dominguez, E, de la Puerta, R, Ruiz-Gutierrez, V. Protective effects upon experimental inflammation models of a polyphenol-supplemented virgin olive oil diet. Inflammation Research 2001; 50 (2): 102–106.
82Carluccio, MA, Siculella, L, Ancora, MA, Massaro, M, Scoditti, E, Storelli, C, et al. . Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of mediterranean diet phytochemicals. Arteriosclerosis, Thrombosis and Vascular Biology 2003; 23 (4): 622–629.
83Kris-Etherton, PM, Yu-Poth, S, Sabate, J, Ratcliffe, HE, Zhao, G, Etherton, TD. Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk. American Journal of Clinical Nutrition 1999; 70 (Suppl. 3): 504S–511S.
84Salas-Salvado, J, Bullo, M, Perez-Heras, A, Ros, E. Dietary fibre, nuts and cardiovascular diseases. British Journal of Nutrition 2006; 96 (Suppl. 2): S45–S51.
85Halvorsen, BL, Holte, K, Myhrstad, MC, Barikmo, I, Hvattum, E, Remberg, SF, et al. . A systematic screening of total antioxidants in dietary plants. Journal of Nutrition 2002; 132 (3): 461–471.
86Cooke, JP, Tsao, P, Singer, A, Wang, BY, Kosek, J, Drexler, H. Anti-atherogenic effect of nuts: is the answer NO? Archives of Internal Medicine 1993; 153 (7): 896–902.
87Fitzpatrick, DF, Hirschfield, SL, Ricci, T, Jantzen, P, Coffey, RG. Endothelium-dependent vasorelaxation caused by various plant extracts. Journal of Cardiovascular Pharmacology 1995; 26 (1): 90–95.
Exler, J, Weihrauch, JL. Provisional tables on the content of omega-3 fatty acids and other fat components of selected foods. Journal of American Dietetic Association 1986; 86 (6): 788–793.
89Zwarts, L, Savage, GP, McNeil, DL. Fatty acid content of new zealand-grown walnuts (juglans regia L.). International Journal of Food Science Nutrition 1999; 50 (3): 189–194.
90Jiang, R, JrJacobs, DR, Mayer-Davis, E, Szklo, M, Herrington, D, Jenny, NS, et al. . Nut and seed consumption and inflammatory markers in the multi-ethnic study of atherosclerosis. American Journal of Epidemiology 2006; 163 (3): 222–231.
91Ros, E, Nunez, I, Perez-Heras, A, Serra, M, Gilabert, R, Casals, E, et al. . A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation 2004; 109 (13): 1609–1614.
92Nash, SD, Westpfal, M. Cardiovascular benefits of nuts. American Journal of Cardiology 2005; 95 (8): 963–965.
93He, FJ, Nowson, CA, MacGregor, GA. Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet 2006; 367 (9507): 320–326.
94van Herpen-Broekmans, WM, Klopping-Ketelaars, IA, Bots, ML, Kluft, C, Princen, H, Hendriks, HF, et al. . Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation. European Journal of Epidemiology 2004; 19 (10): 915–921.
95Watzl, B, Kulling, SE, Moseneder, J, Barth, SW, Bub, A. A 4-wk intervention with high intake of carotenoid-rich vegetables and fruit reduces plasma C-reactive protein in healthy, nonsmoking men. American Journal of Clinical Nutrition 2005; 82 (5): 1052–1058.
96Devaraj, S, Jialal, I. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radical Biology and Medicine 2000; 29 (8): 790–792.
97Sanchez-Moreno, C, Cano, MP, de Ancos, B, Plaza, L, Olmedilla, B, Granado, F, et al. . High-pressurized orange juice consumption affects plasma vitamin C, antioxidative status and inflammatory markers in healthy humans. Journal of Nutrition 2003; 133 (7): 2204–2209.
98Estruch, R, Sacanella, E, Badia, E, Antunez, E, Nicolas, JM, Fernandez-Sola, J, et al. . Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis 2004; 175 (1): 117–123.
99Albert, MA, Glynn, RJ, Ridker, PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation 2003; 107 (3): 443–447.
100Stewart, SH, JrMainous, AG, Gilbert, G. Relation between alcohol consumption and C-reactive protein levels in the adult US population. Journal of the American Board of Family Practice 2002; 15 (6):
101Rahman, I, Biswas, SK, Kirkham, PA. Regulation of inflammation and redox signaling by dietary polyphenols. Biochemical Pharmacology 2006; 72 (11): 1439–1452.
102Marier, JF, Chen, K, Prince, P, Scott, G, del Castillo, JR, Vachon, P. Production of ex vivo lipopolysaccharide-induced tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 is suppressed by trans-resveratrol in a concentration-dependent manner. Canadian Journal of Veterinary Research 2005; 69 (2): 151–154.
103Lotito, SB, Frei, B. Dietary flavonoids attenuate TNFalpha-induced adhesion molecule expression in human aortic endothelial cells: structure–function relationships and activity after first-pass metabolism. Journal of Biological Chemistry 2006 September 20 [Epub ahead of print].
104Rimm, EB, Stampfer, MJ. Wine, beer, and spirits: are they really horses of a different color? Circulation 2002; 105 (24): 2806–2807.
105Estruch, R, Coca, A, Rodicio, JL. High blood pressure, alcohol and cardiovascular risk. Journal of Hypertension 2005; 23 (1): 226–229.
106Trichopoulou, A, Costacou, T, Bamia, C, Trichopoulos, D. Adherence to a Mediterranean diet and survival in a Greek population. New England Journal of Medicine 2003; 348 (26): 2599–2608.
107Esposito, K, Marfella, R, Ciotola, M, Di Palo, C, Giugliano, F, Giugliano, G, et al. . Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. Journal of the American Medical Association 2004; 292 (12): 1440–1446.
108Estruch, R, Martinez-Gonzalez, MA, Corella, D, Salas-Salvado, J, Ruiz-Gutierrez, V, Covas, MI, et al. . Effects of a mediterranean-style diet on cardiovascular risk factors: a randomized trial. Annals of Internal Medicine 2006; 145 (1): 1–11.
109Michalsen, A, Lehmann, N, Pithan, C, Knoblauch, NT, Moebus, S, Kannenberg, F, et al. . Mediterranean diet has no effect on markers of inflammation and metabolic risk factors in patients with coronary artery disease. European Journal of Clinical Nutrition 2006; 60 (4): 478–485.